Search results
Results From The WOW.Com Content Network
In 2010, some former Devgen pharma employees started a pharmaceutical company, Amakem NV, to develop kinase inhibitors they had discovered at Devgen. In 2009, Devgen and Monsanto broadened their collaboration, with Monsanto paying Devgen €20 million cash for broader rights to use Devgen's technology.
Statera BioPharma, Inc. is an American clinical-stage biopharmaceutical company with a focus on novel immunotherapies. In 2021, Cleveland BioLabs merged with Cytocom, Inc, a clinical-stage biopharmaceutical company developing novel immunotherapies targeting autoimmune, inflammatory, infectious diseases, and cancers. [1]
Harrow Health. Harrow Health, Inc., formerly known as Imprimis Pharmaceuticals, is a publicly traded pharmaceutical company based in Nashville, Tennessee . Since 2014, Harrow has started six healthcare businesses, including ImprimisRx, an ophthalmic-focused pharmaceutical company. In 2017, Harrow started and funded Eton Pharmaceuticals with a ...
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
WCLE-FM. / 35.2663889°N 84.8397222°W / 35.2663889; -84.8397222. WCLE-FM (104.1 FM, "Mix 104.1") is a radio station broadcasting an adult contemporary music format. [1] Licensed to Calhoun, Tennessee, the station is currently owned by Hartline, LLC and features programming from Fox News Radio, Vol Network, Titans Radio Network, and ...
3,381. Parent. Pfizer. Website. kingpharm .com. King Pharmaceuticals, Inc. is a pharmaceutical company, a wholly owned subsidiary of Pfizer based in Bristol, Tennessee. Before being acquired by Pfizer, it was the world's 39th largest pharmaceutical company. [1] [2] On October 12, 2010, King was acquired by Pfizer for $14.25 per share. [3]
The Tennessee attorney general's office said Tuesday that it has turned over its investigation into the failed sale of Elvis Presley’s home Graceland at a foreclosure auction to federal ...
The overall economic impact of the bioscience industry in Ohio, including healthcare, amounted to $148.2 billion in 2007, representing 15.7% of Ohio's economic output. [5] Half of the biotech industry is located in northeast Ohio, with 574 firms, while central and southern Ohio are home to around 200 each.